Unresectable Perihilar or Ductal CCA
1 clinical trials · Condition
◉ Watch Unresectable Perihilar or Ductal CCA
| Record | Firm | Date |
|---|---|---|
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma (NCT06440993) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2024-08-23 |
Track Unresectable Perihilar or Ductal CCA automatically
Every clearance here is in the API, with alerts when new ones post.